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[13] or after ultraviolet irradiation [14]. D ifferences, however, 
in molecular weigh t distribution and in affini ty to Con-A of 
fucose-labeled glycopeptides occur 24 hr after stripping com-
pared to normal. S ince t his is markedly earlier than th e peak 
for en tra nce to S-phase it is clear that the molecular changes 
are taking place in the G )-phase of the keratinocyte. 
Previously reported changes of the molecular weight com-
position of fucose-labeled glycopeptides from psoriatic unin-
volved skin [1] appear to be caused by differences in the Con-
A-unbound glycopeptides (Table III). Presumably, the more 
highly branched structures (triantennary and higher) are pre-
sent in reduced quantity in the fucosylated glycoproteins of 
psoriatic uninvolved epidermis compared to normal, in view of 
the results after neuraminidase treatment (Table III). 
The molecular weight distribution of fucose-labeled glyco-
peptides from psoriatic lesions, showing a relative increase in 
high-molecular-weigh t structures compared to normal [1], ap-
pears largely to be the consequence of an increased percentage 
of triantennary and higher-branched structures (Table II) . In 
addition, molecular weigh t distributions of Con-A-bound as 
well as Con-A-unbound glycopeptides from psoriatic lesions 
demonstrate that high-molecular-weight species ar e present to 
a greater exten t tha n in normal skin. In summary, the glyco-
peptide composition observed for psoriatic lesions cannot be 
explained in terms of a n increased growth fraction. This conclu-
sion is valid regardless of whether the increase results from an 
absolute increase in cycling cells, such as occurs during the 
regeneration response, or whether it is a consequence of a 
reduction in the proportion of differentiated cells in the overall 
population. The possibility that our previous findings are of 
direct pathogenic significance for psoriasis is thus considerably 
strengthened. 
We would like to thank Dr. F. W. Bauer for measurements of 
th e DNA con tent by flow cytometry a nd D r. P. D. Mier for 
helpful discussion of this manuscript. 
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